Double Medical(SZ:002901) Sou Hu Cai Jing·2025-09-19 12:45Core Viewpoint - The stock of Dabo Medical (002901) has shown a decline in price and a mixed flow of funds, indicating potential volatility in investor sentiment and market performance [1][2]. Group 1: Stock Performance - As of September 19, 2025, Dabo Medical's stock closed at 53.83 yuan, down 1.41% with a turnover rate of 0.71% and a trading volume of 20,600 shares, resulting in a transaction amount of 111 million yuan [1]. - Over the past five days, the stock has experienced fluctuations in price and fund flows, with a notable net outflow of 10.02 million yuan from main funds on September 19, 2025, which accounted for 8.99% of the total transaction amount [2]. Group 2: Fund Flow Analysis - The fund flow data for September 19, 2025, indicates that retail investors contributed a net inflow of 9.74 million yuan, representing 8.73% of the total transaction amount, while speculative funds saw a net inflow of 0.28 million yuan [1][2]. - The previous days showed a trend of net outflows from main funds, with the highest outflow recorded on September 17, 2025, at 19.66 million yuan, indicating a potential shift in investor confidence [2]. Group 3: Company Financials and Industry Position - Dabo Medical reported a total market capitalization of 22.287 billion yuan, with a net profit of 244 million yuan, reflecting a year-on-year increase of 76.69% [3]. - The company's gross margin stands at 71.01%, significantly higher than the industry average of 51.85%, positioning it favorably within the medical device sector [3]. - Dabo Medical's return on equity (ROE) is 7.6%, which is substantially above the industry average of 1.8%, indicating effective management and profitability [3].